Research team at the TWINCORE and the HZI shows how an enzyme regulates the pathogenicity of a clinically relevant pathogen.
TWINCORE commemorates member of the Board of Clinical Cooperation Partners
HCMV reprograms cellular defence mechanisms
TWINCORE researchers discover promising drug candidate
TWINCORE researchers describe a mechanism that inhibits virus replication and protects cells from damage. Interestingly, a drug that has already been…
The TWINCORE faculty and management place great value on the identification of all staff with the centre.
Here you can view the Gender Equality Plan 2023 of TWINCORE
Lively participation in hands-on event
Immunologist receives 1.5 million euros in funding
Discovery of two novel classes of natural products with activity against RNA viruses
Page 1 of 16.
